Oscar Health posts Q1 2026 non-GAAP EPS $2.07 vs $1.06 est, revenue $4.65B vs $4.91B est, improves margins, membership
- Q1 2026 revenue $4.65B rose 55% YoY and non-GAAP EPS $2.07 increased 125% YoY.
- Company reaffirmed its full-year 2026 guidance alongside the Q1 2026 earnings release.
- In Q1 2026, Oscar Health reported improved medical and SG&A ratios, supporting better overall expense and margin performance.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.